Achilles Therapeutics to present at the 39th Annual J.P. Morgan Healthcare Conference

Published 07 Jan 2021

Achilles Therapeutics to present at the 39th Annual J.P. Morgan Healthcare Conference

Achilles Therapeutics (“Achilles”), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat multiple types of solid tumours today announced that Iraj Ali, Chief Executive Officer, will present at the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021, at 2:00 p.m. ET, 7.00 p.m. GMT.

The live webcast of the presentation will be available in the Events section of the Achilles website.